Evidence map›Paper›PMID 40848227›Full record

ArticleLa Radiologia medica2025

Residual myocardial hyperemia in regadenoson stress/rest quantitative perfusion cardiac magnetic resonance.

Gorka Bastarrika, Ana Ezponda, Javier Muñiz-Sáenz-Diez, Marta Vidorreta, Amaia Ochoa González, Juan José Gavira, Nahikari Salterain

Abstract read
In one paragraph

Article in La Radiologia medica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Gorka BastarrikaDepartment of Radiology, Clinica Universidad de Navarra, Pamplona, Spain. bastarrika@unav.es.ORCID http://orcid.org/0000-0001-9493-6907
Ana EzpondaDepartment of Radiology, Clinica Universidad de Navarra, Pamplona, Spain.
Javier Muñiz-Sáenz-DiezDepartment of Cardiology, Clínica Universidad de Navarra, Pamplona, Spain.
Marta VidorretaSiemens Healthineers, Madrid, Spain.
Amaia Ochoa GonzálezDepartment of Cardiology, Clínica Universidad de Navarra, Pamplona, Spain.
Juan José GaviraDepartment of Cardiology, Clínica Universidad de Navarra, Pamplona, Spain.
Nahikari SalterainDepartment of Cardiology, Clínica Universidad de Navarra, Pamplona, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThis study sought to investigate the presence of residual myocardial hyperemia on the recovery phase in patients undergoing stress CMR. MATERIAL AND

methodsFifty patients with clinical indication for stress CMR underwent quantitative perfusion imaging in resting conditions, after regadenoson-induced hyperemia (400 mcg, 5 mL), and 10 min after recovery with euphylline. Studies showing hypoperfusion due to ischemia and/or prior myocardial infarction were excluded. Global myocardial blood flow during rest (MBF

resultsA total of 30 patients (22 males, mean age of 62.7 ± 1 years) were included in the analysis. Global MBF

conclusionDespite the use of euphylline to counteract the vasodilator effect, MBF does not completely revert to resting values and MBF

Indexed as

HyperemiaMagnetic Resonance ImagingMyocardial Perfusion ImagingPurinesPyrazolesAgedCoronary CirculationExercise TestFemaleHumansMaleMiddle AgedVasodilator AgentsPurinesPyrazolesregadenosonVasodilator AgentsCardiac magnetic resonanceCoronary artery diseasePerfusionVasodilator

Identifiers

PMID40848227
PMCPMC12605555

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.